Skip to main content
S

Suven Life Sciences Ltd. — Investor Relations & Filings

Ticker · SUVEN ISIN · INE495B01038 LEI · 3358001IFOGM16J8ZA04 BSE.NS Professional, scientific and technical activities
Filings indexed 0 across all filing types
Latest filing no filings yet
Country IN India
Listing BSE.NS SUVEN

About Suven Life Sciences Ltd.

https://www.suven.com/

Suven Life Sciences Ltd. focuses on the discovery and development of novel therapeutic agents for Central Nervous System (CNS) disorders. The company specializes in New Chemical Entity (NCE) research, targeting unmet medical needs in conditions such as Alzheimer’s disease, schizophrenia, attention deficit hyperactivity disorder (ADHD), Huntington’s disease, Parkinson’s disease, and depression. Its clinical pipeline includes lead candidates like Masupirdine (SUVN-502) for cognitive impairment and Samelisant (SUVN-G3031) for narcolepsy. Suven utilizes an integrated drug discovery platform and maintains a significant global intellectual property portfolio. The organization provides drug discovery and development support services, leveraging expertise in medicinal chemistry and pharmacology to advance internal programs and collaborative research initiatives.

Recent filings

No filings indexed yet

We are still gathering filings for Suven Life Sciences Ltd.. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.